Lv11
40 积分 2024-02-22 加入
A cost-effectiveness analysis of amivantamab plus lazertinib versus osimertinib in the treatment of US and Chinese patients with EGFR-mutated advanced non-small cell lung cancer
1小时前
已完结
Primary and metastatic peritoneal surface malignancies
2个月前
已完结
Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R
9个月前
已完结
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota
1年前
已完结
皖公网安备34019202002308
